Page last updated: 2024-09-04

ruboxistaurin and tetrodotoxin

ruboxistaurin has been researched along with tetrodotoxin in 2 studies

Compound Research Comparison

Studies (ruboxistaurin)	Trials (ruboxistaurin)	Recent Studies (post-2010) (ruboxistaurin)	Studies (tetrodotoxin)	Trials (tetrodotoxin)	Recent Studies (post-2010) (tetrodotoxin)
203	29	56	12,992	11	1,477

Protein Interaction Comparison

Protein	Taxonomy	ruboxistaurin (IC50)	tetrodotoxin (IC50)
Sodium channel protein type 9 subunit alpha	Homo sapiens (human)		0.0186

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kashiwagi, A; Kim, H; Koya, D; Maeda, K; Sasaki, T; Yasuda, H	1
Hayase, F; Kashiwagi, A; Kitada-Hamada, K; Maeda, K; Matsuura, H; Omatsu-Kanbe, M; Sanada, M; Yasuda, H	1

Other Studies

2 other study(ies) available for ruboxistaurin and tetrodotoxin

Article	Year
Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons. Diabetes, 2003, Volume: 52, Issue:8 Topics: Animals; Arginine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Ganglia, Spinal; Immunohistochemistry; Indoles; Male; Maleimides; NAV1.9 Voltage-Gated Sodium Channel; Neuropeptides; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nociceptors; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Sodium Channels; Tetrodotoxin	2003
Inhibitory action of protein kinase Cbeta inhibitor on tetrodotoxin-resistant Na+ current in small dorsal root ganglion neurons in diabetic rats. Neuroscience letters, 2007, Apr-24, Volume: 417, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Indoles; Male; Maleimides; Membrane Potentials; Neural Conduction; Neurons, Afferent; Patch-Clamp Techniques; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin	2007

Article

Year

Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons.

Diabetes, 2003, Volume: 52, Issue:8

Topics: Animals; Arginine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Ganglia, Spinal; Immunohistochemistry; Indoles; Male; Maleimides; NAV1.9 Voltage-Gated Sodium Channel; Neuropeptides; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nociceptors; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Sodium Channels; Tetrodotoxin

2003

Inhibitory action of protein kinase Cbeta inhibitor on tetrodotoxin-resistant Na+ current in small dorsal root ganglion neurons in diabetic rats.

Neuroscience letters, 2007, Apr-24, Volume: 417, Issue:1

Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Indoles; Male; Maleimides; Membrane Potentials; Neural Conduction; Neurons, Afferent; Patch-Clamp Techniques; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin

2007